Evidence map›Paper›PMID 23948431›Full record

ReviewTrends in parasitology2013

IRONy OF FATE: role of iron-mediated ROS in Leishmania differentiation.

Bidyottam Mittra, Norma W Andrews

Abstract readReview
In one paragraph

Review in Trends in parasitology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Oxidative Stress and Survival ofExpert reviews in molecular medicine · 2025
    Review
  3. Review
  4. Article
  5. Anti-Frontiers in microbiology · 2023
    Article
  6. Review
  7. Lysosome Sensing Is a Key Mechanism inFrontiers in microbiology · 2021
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. TheThe Yale journal of biology and medicine · 2019
    Review
  13. Deciphering the Role Played by Autophagy inFrontiers in immunology · 2019
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Bidyottam MittraDepartment of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD, USA.
Norma W Andrews

Funding

Molecular Determinants of Intracellular Survival and Replication in LeishmaniaR01AI067979 · NIAID · YALE UNIVERSITY · PI ANDREWS, NORMA WINDSOR · 2007 to 2018
$3.8M
LYSOSOME-MEDIATED CELL INVASION BY TRYPANOSOMA CRUZIR01AI034867 · NIAID · YALE UNIVERSITY · PI ANDREWS, NORMA WINDSOR · 1994 to 2003
$880k
NIAID NIH HHS R01 AI034867NIAID NIH HHS R01 AI067979
6 · The paper itself

Abstract

The protozoan parasite Leishmania experiences extreme environmental changes as it alternates between insect and mammalian hosts. In some species, differentiation of insect promastigotes into mammalian-infective amastigotes is induced by elevated temperature and low pH, conditions found within macrophage parasitophorous vacuoles (PVs). However, the signaling events controlling amastigote differentiation remain poorly understood. Recent studies revealed a novel role for iron uptake in orchestrating the differentiation of amastigotes, through a mechanism that involves production of reactive oxygen species (ROS) and is independent from pH and temperature changes. ROS are generally thought to be deleterious for pathogens, but it is becoming increasingly apparent that they can also function as signaling molecules regulating Leishmania differentiation, in a process that is tightly controlled by iron availability.

Indexed as

Cell DifferentiationAutophagyHumansIronLeishmaniaMacrophagesReactive Oxygen SpeciesSignal TransductionIronReactive Oxygen SpeciesdifferentiationFeSODironLeishmaniaROSvirulence

Identifiers

PMID23948431
PMCPMC3783550

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.